TGF-β signaling of human T cells is modulated by the ancillary TGF-β receptor endoglin

International Immunology

Volumn 17, Issue 7, 2005, Pages 921-930

  Schmidt Weber, Carsten B ^a   Letarte, Michelle ^b   Kunzmann, Steffen ^a   Rückert, Beate ^a   Bernabéu, Carmelo ^c   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Cytokine receptor; T lymphocytes; Tolerance Suppression anergy

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; ENDOGLIN; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; SMAD PROTEIN; THREONINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CELL SURFACE; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOCYTE MEMBRANE; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE I; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 26444519503     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh272     Document Type: Article

References (44)

1. Gorelik, L. and Flavell, R. A. 2002. Transforming growth factor-beta in T -cell biology. Nat. Rev. Immunol. 2:46.
2. Gorelik, L. and Flavell, R. A. 2000. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171.
3. Hansen, G., McIntire, J. J., Yeung, V. P. et al. 2000. CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J. Clin. Invest. 105:61.
4. Nakao, A., Miike, S., Hatano, M. et al. 2000. Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of smad7 enhances antigen-induced airway inflammation and airway reactivity [In Process Citation]. J. Exp. Med. 192:151.
5. Nakao, A. 2001. Is TGF-beta1 the key to suppression of human asthma? Trends Immunol. 22:115.
6. Dong, Y., Tang, L., Letterio, J. J. and Benveniste, E. N. 2001. The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J. Immunol. 167:311.
7. Hu, X. and Zuckerman, K. S. 2001. Transforming growth factor: Signal transduction pathways, cell cycle mediation, and effects on hematopoiesis. J. Hematother. Stem Cell Res. 10:67.
8. Derynck, R. and Zhang, Y. E. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577.
9. Chen, C. H., Seguin-Devaux, C., Burke, N. A. et al. 2003. Transforming growth factor beta blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J. Exp. Med. 197:1689.
10. Willard, F. S. and Crouch, M. F 2001. MEK, ERK, and p90RSK are present on mitotic tubulin in Swiss 3T3 cells: A role for the MAP kinase pathway in regulating mitotic exit. Cell. Signal. 13:653.
11. Choy, L. and Derynck, R. 1998. The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J. Biol. Chem. 273:31455.
12. Griswold-Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C. and Derynck, R. 1998. Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol. Cell. Biol. 18:6595.
13. Cheifetz, S., Bellon, T., Cales, C. et al. 1992. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J. Biol. Chem. 267:19027.
14. Barbara, N. P., Wrana, J. L. and Letarte, M. 1999. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily. J. Biol. Chem. 274:584.
15. Letamendia, A., Lastres, P., Botella, L. M. et al. 1998. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J. Biol. Chem. 273:33011.
16. Quackenbush, E. J. and Letarte, M. 1985. Identification of several cell surface proteins of non-T, non-B acute lymphoblastic leukemia by using monoclonal antibodies. J. Immunol. 134:1276.
17. Buhring, H. J., Muller, C. A., Letarte, M. et al. 1991. Endoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 5:841.
18. Rokhlin, O. W., Cohen, M. B., Kubagawa, H., Letarte, M. and Cooper, M. D. 1995. Differential expression of endoglin on fetal and adult hematopoietic cells in human bone marrow. J. Immunol. 154:4456.
19. Lastres, P., Bellon, T., Cabanas, C. et al. 1992. Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen. Eur J. Immunol. 22:393.
20. Zhang, H., Shaw, A. R., Mak, A. and Letarte, M. 1996. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. J. Immunol. 156:564.
21. Dagdeviren, A., Muftuoglu, S. F, Cakar, A. N. and Ors, U. 1998. Endoglin (CD 105) expression in human lymphoid organs and placenta. Anal. Anz. 180:461.
22. McAllister, K. A., Grogg, K. M., Johnson, D. W. et al. 1994. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 8:345.
23. Pece, N., Vera, S., Cymerman, U., White, R. I., Jr, Wrana, J. L. and Letarte, M. 1997. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J. Clin. Invest. 100:2568.
24. Shovlin, C. L. and Letarte, M. 1999. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 54:714.
25. Pece-Barbara, N., Cymerman, U., Vera, S., Marchuk, D. A. and Letarte, M. 1999. Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum. Mol. Genet. 8:2171.
26. Cymerman, U., Vera, S., Pece-Barbara, N. et al. 2000. Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr. Res. 47:24.
27. Lastres, P., Letamendia, A., Zhang, H. et al. 1996. Endoglin modulates cellular responses to TGF-beta 1. J. Cell Biol. 133:1109.
28. Li, C., Hampson, I. N., Hampson, L., Kumar, P., Bernabeu, C. and Kumar, S. 2000. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB J. 14:55.
29. Caniggia, I., Taylor, C. V., Ritchie, J. W., Lye, S. J. and Letarte, M. 1997. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138:4977.
30. Schmidt-Weber, C. B., Alexander, S. I., Henault, L. E., James, L. and Lichtman, A. H. 1999. IL-4 enhances IL-10 gene expression in murine Th2 cells in the absence of TCR engagement. J. Immunol. 162:238.
31. Schmidt-Weber, C. B., Wohlfahrt, J. G., Akdis, C. and Blaser, K. 2002. The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells. Eur J. Immunol. 32:1196.
32. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. and Gauthier, J. M. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:3091.
33. Pichuantes, S., Vera, S., Bourdeau, A. et al. 1997. Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments. Tissue Antigens 50:265.
34. Akdis, C. A., Joss, A., Akdis, M., Faith, A. and Blaser, K. 2000. A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding. FASEB J. 14:1666.
35. Kunzmann, S., Wohlfahrt, J. G., Itoh, S. et al. 2003. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression. FASEB J. 17:194.
36. Schmidt-Weber, C. B., Kunzmann, S. and Blaser, K. 2002. TGF-beta-mediated control of allergen-specific T cell responses. Curr. Allergy Asthma Rep. 2:259.
37. Mamura, M., Nakao, A., Goto, D., Kato, M., Saito, Y. and Iwamoto, I. 2000. Ligation of the T cell receptor complex results in phosphorylation of Smad2 in T lymphocytes. Biochem. Biophys. Res. Commun. 268:124.
38. Cottrez, F. and Groux, H. 2001. Regulation of TGF-beta response during Tcell activation is modulated by IL-10. J. Immunol. 167:773.
39. Eickelberg, O., Centrella, M., Reiss, M., Kashgarian, M. and Wells, R. G. 2002. Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function. J. Biol. Chem. 277:823.
40. Nakamura, K., Kitani, A. and Strober, W. 2001. Cell contact-dependent immunosuppress ion by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:629.
41. Watanabe, H., de Caestecker, M. P. and Yamada, Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J. Biol. Chem. 276:14466.
42. Kretzschmar, M., Doody, J., Timokhina, I. and Massague, J. 1999. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev 13:804.
43. Runyan, C. E., Schnaper, H. W. and Poncelet, A. C. 2004. The PI3K-Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to TGF-beta 1. J. Biol. Chem. 279:2632.
44. Horowitz, J. C., Lee, D. Y., Waghray, M. et al. 2004. Activation of the pro-survival PI3K/Akt pathway by transforming growth factor-beta 1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J. Biol. Chem. 279:1359.